Literature DB >> 10698344

On the role of complement and Fc gamma-receptors in the Arthus reaction.

J Köhl1, J E Gessner.   

Abstract

The contribution of either the complement system or the activation of Fc receptors for IgG (FcyRs) to the inflammatory response in immune complex (IC) disease is puzzling. A series of studies has been performed in mice with engineered deficiencies of either FcgammaRs, the complement components C3, C4 or the C5a receptor. In addition, different C5-deficient mice strains have been evaluated. Mice with gene targeted disruption of the gamma-subunit, which mediates surface expression and signal transduction of the high affinity Fc receptor type I for IgG (FcgammaRI), the low affinity receptor Fc receptor type III for IgG (FcgammaRIII) and the high affinity receptor type I for IgE (IgepsilonRI), showed an impaired inflammatory response in the reverse passive Arthus reaction in skin, peritoneum and lung. These data suggest, that the activation of FgammaRs is the initial event triggering the inflammatory cascade in IC disease. On the other hand, C5aR deficient mice are either protected from tissue injury induced by ICs, as in the lung, or the degree of the inflammatory response is markedly attenuated, as in peritoneum and skin. A detailed analysis of data obtained with the different knock-out strains revealed that both the activation of the complement system as well as the activation of different effector cells via FcgammaRs contribute to the inflammatory sequelae leading to tissue destruction in IC disease. The relative contributions of FcgammaRI or FcgammaRIII and the main effector cells through which these receptors mediate their effector functions are tissue dependent. The activation of the C5a receptor pathway appears to be the prominent contribution of the complement system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10698344     DOI: 10.1016/s0161-5890(99)00111-x

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  18 in total

1.  A full complement of receptors in immune complex diseases.

Authors:  Jeffrey V Ravetch
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis.

Authors:  Hongmei Gu; Elizabeth A Mickler; Oscar W Cummings; George E Sandusky; Daniel J Weber; Adam Gracon; Trent Woodruff; David S Wilkes; Ragini Vittal
Journal:  FASEB J       Date:  2014-06-23       Impact factor: 5.191

3.  C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.

Authors:  Nelli Shushakova; Julia Skokowa; Jurriaan Schulman; Ulrich Baumann; Jörg Zwirner; Reinhold E Schmidt; J Engelbert Gessner
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

4.  Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist.

Authors:  A J Strachan; I A Shiels; R C Reid; D P Fairlie; S M Taylor
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

5.  Relative contributions of selectins and intercellular adhesion molecule-1 to tissue injury induced by immune complex deposition.

Authors:  Koichi Yanaba; Yuko Kaburagi; Kazuhiko Takehara; Douglas A Steeber; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

6.  Platelets control leukocyte recruitment in a murine model of cutaneous arthus reaction.

Authors:  Toshihide Hara; Kazuhiro Shimizu; Fumihide Ogawa; Koichi Yanaba; Yohei Iwata; Eiji Muroi; Motoi Takenaka; Kazuhiro Komura; Minoru Hasegawa; Manabu Fujimoto; Shinichi Sato
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

7.  Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.

Authors:  M Fung; M Lu; H Fure; W Sun; C Sun; N Y Shi; Y Dou; J Su; X Swanson; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

8.  Establishment of experimental eosinophilic vasculitis by IgE-mediated cutaneous reverse passive arthus reaction.

Authors:  Takayuki Ishii; Tomoyuki Fujita; Takashi Matsushita; Koichi Yanaba; Minoru Hasegawa; Hiroko Nakashima; Fumihide Ogawa; Kazuhiro Shimizu; Kazuhiko Takehara; Thomas F Tedder; Shinichi Sato; Manabu Fujimoto
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

9.  Skewed balance in basal expression and regulation of activating v inhibitory Fcgamma receptors in macrophages of collagen induced arthritis sensitive mice.

Authors:  A B Blom; P L E M van Lent; A E M Holthuysen; C Jacobs; W B van den Berg
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

10.  Cross-talk between TLR4 and FcgammaReceptorIII (CD16) pathways.

Authors:  Daniel Rittirsch; Michael A Flierl; Danielle E Day; Brian A Nadeau; Firas S Zetoune; J Vidya Sarma; Clement M Werner; Guido A Wanner; Hans-Peter Simmen; Markus S Huber-Lang; Peter A Ward
Journal:  PLoS Pathog       Date:  2009-06-05       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.